Stool (amide-)N-methylnicotinamide

There is 1 paper on stool (amide-)N-methylnicotinamide in aging research: none in people yet, 1 in animals. The newest story, Nov 6, 2026: “Bacterial compound promotes gut stem cell renewal in mice”.

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on stool (amide-)N-methylnicotinamide

“Patients with gut dysbiosis and inflammation show reduced stool N-MNA.”
The (amide-)N-methylnicotinamide is a microbe-derived NAD ⁺ precursor that drives gut stem cell renewalScience advances2026doi:10.1126/sciadv.aef2882
  • Animals1

Associations

1

Gut dysbiosis and inflammation

mixedin humans1

1 study
  1. Stool (amide-)N-methylnicotinamide is associated with gut dysbiosis and inflammation in humans (Reduced stool N-MNA in affected patients).

    “Patients with gut dysbiosis and inflammation show reduced stool N-MNA.”

    Humansstool

    Bacterial compound promotes gut stem cell renewal in mice

    Science advances

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Science Advances

Bacterial compound promotes gut stem cell renewal in mice

In mouse experiments, supplementation with a compound made by certain gut bacteria promoted intestinal stem cell regeneration and repair of the gut lining.In mouse experiments, supplementation with a compound made by certain gut bacteria promoted intestinal stem cell regeneration and repair of the gut lining.